ACIDULATED PHOSPHATE FLUORIDE ORAL SOLUTION .017 %
HYDROGEN FLUORIDE : .017 % SODIUM FLUORIDE : .65 % · DIN 02117339 · PDT IMAGE INC. DBA PRO-DENTEC CANADA
Health Canada status: CANCELLED POST MARKET
What is ACIDULATED PHOSPHATE FLUORIDE ORAL SOLUTION?
ACIDULATED PHOSPHATE FLUORIDE ORAL SOLUTION .017 % contains HYDROGEN FLUORIDE : .017 % SODIUM FLUORIDE : .65 %. It is listed in the Health Canada Drug Product Database under DIN 02117339, held by PDT IMAGE INC. DBA PRO-DENTEC CANADA, supplied as SOLUTION for DENTAL administration. Health Canada currently lists it as cancelled post market, status dated 30-Jul-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02117339 |
|---|---|
| Brand name | ACIDULATED PHOSPHATE FLUORIDE ORAL SOLUTION |
| Generic / active ingredient | HYDROGEN FLUORIDE : .017 % SODIUM FLUORIDE : .65 % |
| Manufacturer | PDT IMAGE INC. DBA PRO-DENTEC CANADA |
| Strength | .017 % |
| Dosage form | SOLUTION |
| Route of administration | DENTAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A01AA30 COMBINATION (CARIES PROPHYLACTIC AGENTS) |
| AHFS class | 34:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 30-Jul-1999 |
| Original market date | 1995-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A01AA30 COMBINATION (CARIES PROPHYLACTIC AGENTS). 0 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PASCAL PUFF | 1.23 % | LIQUID | PASCAL INTERNATIONAL CORPORATION | CANCELLED POST MARKET | DIN 02241675 |
| PDF GEL 1.24% | 1.24 % | GEL | LAB BMG INC. | CANCELLED POST MARKET | DIN 00461024 |
| PERFECT CHOICE 0.717% ROOT AND DENTIN DESENS | .14 % | LIQUID | CHALLENGE PRODUCTS INC. | CANCELLED POST MARKET | DIN 02044951 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.